Masimo (MASI) Has Strong Case for Sales Growth, Margin Expansion - Stifel

Stifel analyst Rick Wise reiterated a Buy rating and $180.00 price target on Masimo Corp. (NASDAQ: MASI).

The analyst commented, "Masimo’s 2025 Investor Day left us with a clearer impression of both Masimo's positive growth outlook broadly and the underlying drivers supporting those longterm aspirations. Targeting over the 2026-2028 period a 7%-10% revenue CAGR, 2028 operating margins of ~30%, and EPS of $8.00 (vs. our $6.86 estimate), these goals could be viewed as ambitious. However, CEO Katie Syzman and her team thoughtfully-conveyed a new energy and new vision at Masimo, revolving around “focus, innovation, and execution”. To us, MASI laid out a credible case for continued strong sales growth, solid operating margin expansion, and improving profitability ahead...with room for upside. We strongly believe that the steady cadence of new product innovation (some announced today and more to come), accumulation of product-differentiating clinical data, more-disciplined go-to-market approaches, and considerable potential for positive operating leverage all offer the opportunity for upside performance over time."

For an analyst ratings summary and ratings history on Masimo Corp. click here. For more ratings news on Masimo Corp. click here.

Shares of Masimo Corp. closed at $138.09 yesterday.

You May Also Be Interested In

• Phillips 66, Marathon Merger Talks Collapsed - Semafor
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'